Effect of various estrogen treatment schedules on antithrombin III levels. 1976

J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo

Antithrombin III levels were determined in 18 normal indiviuals of both sexes, 24 pregnant women (at term), 20 patients treated with oral contraceptives and 21 postmenopausal patients treated with Premarin. There was no sex difference in antithrombin III levels in the untreated control group. Pregnant women at term had the lowest levels of antithrombin III. The second lowest values were exhibited by women on oral contraceptives. Both of these groups differed significantly (p less than 0.05) from the controls. Premarin treated postmenopausal women had somewhat lower levels of antithrombin III than controls but these were statistically not significant.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000991 Antithrombins Endogenous factors and drugs that directly inhibit the action of THROMBIN, usually by blocking its enzymatic activity. They are distinguished from INDIRECT THROMBIN INHIBITORS, such as HEPARIN, which act by enhancing the inhibitory effects of antithrombins. Antithrombin,Direct Antithrombin,Direct Antithrombins,Direct Thrombin Inhibitor,Direct Thrombin Inhibitors,Antithrombin, Direct,Antithrombins, Direct,Inhibitor, Direct Thrombin,Thrombin Inhibitor, Direct,Thrombin Inhibitors, Direct

Related Publications

J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
January 1979, Medical and pediatric oncology,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
August 1982, Journal of the American Medical Women's Association (1972),
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
May 1989, Hinyokika kiyo. Acta urologica Japonica,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
August 1987, Ginekologia polska,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
April 1977, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
January 1978, JAMA,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
August 1976, The American journal of medicine,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
January 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
September 1988, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J L Ambrus, and C M Ambrus, and M A Lillie, and B J Browne, and F W Hanson, and K Niswander, and M Witul, and O S Jung, and A Bartfay-Szabo
March 1998, Acta obstetricia et gynecologica Scandinavica,
Copied contents to your clipboard!